utilization, new antimicrobials, and educational content, including infectious diseases treatment guidelines and mechanisms of antimicrobial action and resistance. The Co-Editors and the Editorial Board will continuously update and augment the Web site with the most current data, new studies, animations of antimicrobial action and resistance, and information on new antimicrobials. Web site users will find these resource 'tools' highly conducive to both learning and teaching. An important aspect of this Web site will be the availability of extensive downloads, including PowerPoint presentations on antimicrobial and antifungal resistance and usage, and infectious diseases treatment guidelines.
The major target audience of this site will be infectious diseases specialists (teaching and non-teaching), medical microbiologists, clinical and basic microbiologists, clinical pharmacists and nurses. In addition, researchers, respirologists, intensivists, urologists, hospital clinicians and surgeons will also be important audiences who will greatly benefit from this Web site. The CAN-R Web site will be a multisponsored, multiendorsed initiative with support from the Association of Medical Microbiology and Infectious Disease Canada and the Public Health Agency of Canada. The CAN-R Web site will actively seek partnerships and collaborations with existing Canadian and international organizations concerned about antimicrobial-resistant infections. We look forward to working hard along with our Editorial Board to provide Canadian physicians and scientists the latest information regarding antimicrobial and antifungal resistance and usage issues. 
